The platform of the vaccine has yet to be disclosed
Virus-like particle (VLP) technology is a very powerful method for developing vaccines. VLPs mimic the conformation […]
A subunit vaccine is a fragment of a pathogen, typically a surface protein, that is used […]
Live vaccines use a weakened (or attenuated) form of the germ that causes a disease. Because […]
Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or tissues. […]
Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or tissues. […]
An inactivated vaccine (or killed vaccine) is a vaccine consisting of virus particles, bacteria, or other […]
Genetically engineered DNA can be delivered in vaccine form and elicit an immune response
Just like normal vaccines, RNA vaccines are intended to induce the production of antibodies which will […]
The phase 4 trial is also referred to as post-marketing surveillance, it is conducted after the […]